000566 海南海药
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-15.417-5.0380.487-53.128-14.210
总资产报酬率 ROA (%)-4.029-1.4460.134-16.687-5.511
投入资产回报率 ROIC (%)-4.973-1.7800.169-20.173-6.472

边际利润分析
销售毛利率 (%)34.76738.55943.18240.35943.712
营业利润率 (%)-37.908-8.160-3.456-75.336-32.242
息税前利润/营业总收入 (%)-23.2102.5046.091-65.951-24.922
净利润/营业总收入 (%)-38.980-9.1540.133-77.590-29.749

收益指标分析
经营活动净收益/利润总额(%)80.293166.518323.76230.24793.250
价值变动净收益/利润总额(%)16.300-14.974-334.87010.420-20.069
营业外收支净额/利润总额(%)1.167-1.751-4.3950.3060.385

偿债能力分析
流动比率 (X)0.6130.6700.6310.7511.039
速动比率 (X)0.4880.5840.5620.6960.979
资产负债率 (%)74.11970.13068.26971.48361.363
带息债务/全部投入资本 (%)58.97556.57457.62857.269--
股东权益/带息债务 (%)50.95960.82862.88358.02577.455
股东权益/负债合计 (%)32.70839.92243.05135.95358.756
利息保障倍数 (X)-1.5320.2380.648-6.858-3.348

营运能力分析
应收账款周转天数 (天)119.16683.75081.892104.0390.000
存货周转天数 (天)198.221118.47695.65382.2300.000